COVID-19 death risk doubles for patients with cardiovascular disease, cancer

Cardiovascular diseases and cancer significantly increased the risk of death for patients who contracted COVID-19, a new study found.

Advertisement

The study, which has not been peer-reviewed, examined the link between certain preexisting conditions and COVID-19 mortality. Researchers searched several databases, including Medline and Ovid, for studies published between Dec. 1, 2019, and May 1. They included 19 studies in the meta-analysis. The 19 studies involved 61,455 patients with COVID-19.

Coronary heart disease, hypertension, congestive heart failure and cancer significantly increased the risk of mortality from COVID-19.

The risk of death from COVID-19 was:

● 2.4 times as high for those with coronary heart disease, compared to those without
● 2 times as high for those with hypertension, compared to those without
● 2.5 times as high for those with congestive heart failure, compared to those without
● 2 times as high for those with cancer, compared to those without

More articles on oncology:
Memorial Sloan Kettering posts $62M operating loss in Q1
How the pandemic is affecting cancer research
Dr. Pier Paolo Pandolfi joins Desert Research Institute, Renown Health

At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.

Advertisement

Next Up in Oncology

Advertisement